Home › Graves Disease › North Carolina
Graves Disease clinical trials in North Carolina
11 studies for Graves Disease are looking for participants at sites in North Carolina.
Cities in North Carolina
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-038, Asheville
- Site-011, Greenville
- Site-063, Morehead City
- and 4 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 12, 2026 · NCT07661056A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Asheville Clinical Research, Asheville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07722546A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Asheville Clinical Research, Asheville
- Wake Internal Medicine Consultants, Raleigh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07570316Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 131, Cary
- Site 134, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1010, Chapel Hill
- Site Number - 1026, Hickory
- Site Number - 1001, Morehead City
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 30, 2026 · NCT07018323NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1106, Morehead City
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Oct 29, 2026 · NCT07305818Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
- Site 113, Wilmington
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07885605Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
- Asheville Clinical Trials, Asheville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07753603A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1051, Asheville
- Site Number - 1060, Wilmington
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
- Site-108, Greenville
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
- Appalachian State University, Boone
Recruiting
Ages 18 to 65 · All sexes · Updated Jul 30, 2026 · NCT07413874From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.